Showing results (1661-1670 of 6,884) with videos related to
Sort By:
Pageof 689
Leukemia Research|April 19, 2025
Safety and efficacy of the combination of azacitidine with venetoclax after hypomethylating agent failure in higher-risk myelodysplastic syndromeJulie S Braish, Guillermo Montalban-Bravo, Farhad Ravandi, et al.Leukemia Research|March 4, 2025
Outcomes of triple-class refractory multiple myeloma patients at a single clinic: A retrospective studyRyan Danis, Sean Bujarski, David Yashar, et al.Leukemia Research|March 1, 2025
Complementing therapeutic strategies for acute myeloid leukemia: Signaling pathways and targets of traditional Chinese medicineQiaoliang Wu, Lei Zhong, Guibing Zhang, et al.Leukemia Research|February 28, 2025
Molecular genetic characterization of mixed-phenotype acute leukemia (MPAL) with BCR::ABL1 fusionSophia Shi, Qianghua Zhou, Davidson Zhao, et al.Leukemia Research|June 15, 2024
Molecular characterization of V(D)J rearrangements in immature acute leukemiasDanielle Tavares Vianna, Barbara da Costa Reis Monte-Mór, Elda Pereira Noronha, et al.Leukemia Research|June 21, 2024
Unmutated IGHV at diagnosis in patients with early stage CLL independently predicts for shorter follow-up time to first treatment (TTFT)Piero Galieni, Emanuela Troiani, Paola Picardi, et al.Leukemia Research|May 31, 2024
Molecular prognostication for transplant decision making of patients with myelodysplastic syndromes: A retrospective single-center studyAnnalisa Condorelli, Marco Frigeni, Giulia Quaresmini, et al.Leukemia Research|June 8, 2024
Impact of leukemia-associated macrophages on the progression and therapy response of chronic lymphocytic leukemiaHendrik Jestrabek, Viktoria Kohlhas, Michael Hallek, et al.Leukemia Research|May 18, 2024
Single vs double umbilical cord blood transplantation in acute leukemia: Systematic review and meta-analysisPeter Olujimi Odutola, Peter Oluwatobi Olorunyomi, Ifeoluwapo OlorunyomiLeukemia Research|December 28, 2025
Efficacy and safety of PD-1/PD-L1 inhibitors in combination with chemotherapy or CAR-T cells for relapsed/refractory acute lymphoblastic leukemia: A multicenter phase ii trialMin Zou, Bolin Wan, Jing HuPageof 689